All In MedTech

Device Trial Radar · NCT01325623

Seizure Detection and Automatic Magnet Mode Performance Study

Last checked: Nov 20, 2026Latest source record: Jan 22, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

31

Actual

Start

Mar 2011

Primary completion

Jul 2013

Study completion Jul 2015

Sponsor

Lead sponsor
Cyberonics, Inc.Public (LIVN)
Sponsor type
Industry
Collaborators
PRA Health Sciences
First posted
Mar 30, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to confirm cardiac-based seizure detection in Cyberonics Model 106 VNS Therapy System.

Conditions

  • Epilepsy

Interventions

  • Model 106 VNS Therapy SystemDevice

    The VNS Therapy System is an adjunctive therapy for the treatment of epilepsy. VNS Therapy is available as a scheduled stimulation, this is cyclic stimulation between programmable On- and Off- times (e.g., a 30-second burst every 5 minutes). VNS Therapy is also available as on-demand stimulation, that is, when a magnet is introduced briefly over the implanted device (Magnet Mode). The AspireSR VNS Therapy System includes a new feature, Automatic Magnet Mode or AutoStim. In addition to Normal Mode and Magnet Mode, AspireSR uses a Seizure Detection Algorithm to identify a potential seizure onset based on associated heart rate increases known as ictal tachycardia. The purpose is to deliver stimulation at or near the onset of a seizure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Summary of Seizures Reported by Investigators and Triple ReviewTime frame: Epilepsy Monitoring Unit Stay
  2. Observed Sensitivity Based on Heart Rate Increase Associated With Seizures by Randomized SDA SettingTime frame: Epilepsy Monitoring Unit (EMU) Stay
  3. Modeled Sensitivity Based on Heart Rate Increase Associated With Seizures by SDA Setting Post-Processed Through Bench-top Device SimulantTime frame: Epilepsy Monitoring Unit (EMU) Stay

1 more outcomes with a free account

Locations

14 sites in 5 countries. Site status is shown where the registry gives one.

  • Hôpital Erasme

    Anderlecht, Belgium

  • Cliniques Universitaires Saint-Luc

    Brussels, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

11 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.